Albert Parés

Active 1985–2025

Also published as
Albert Pares
112
Papers
19,186
Citations
77
h-index
109
i10-index

Citations

Citations per year for Albert Parés1987: 5 citations1988: 2 citations1989: 2 citations1990: 5 citations1991: 5 citations1992: 14 citations1993: 17 citations1994: 15 citations1995: 21 citations1996: 14 citations1997: 20 citations1998: 26 citations1999: 25 citations2000: 47 citations2001: 59 citations2002: 63 citations2003: 79 citations2004: 54 citations2005: 80 citations2006: 62 citations2007: 83 citations2008: 91 citations2009: 82 citations2010: 99 citations2011: 80 citations2012: 68 citations2013: 112 citations2014: 76 citations2015: 174 citations2016: 76 citations2017: 169 citations2018: 162 citations2019: 539 citations2020: 578 citations2021: 580 citations2022: 647 citations2023: 547 citations2024: 906 citations2025: 449 citations2026: 19 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,379 citing papers, 18.3% of this breakdownUnited Kingdom: 659 citing papers, 8.7% of this breakdownItaly: 523 citing papers, 6.9% of this breakdownChina: 518 citing papers, 6.9% of this breakdownGermany: 495 citing papers, 6.6% of this breakdownSpain: 422 citing papers, 5.6% of this breakdownCanada: 345 citing papers, 4.6% of this breakdownFrance: 297 citing papers, 3.9% of this breakdownNetherlands: 271 citing papers, 3.6% of this breakdownJapan: 183 citing papers, 2.4% of this breakdownSwitzerland: 155 citing papers, 2.1% of this breakdownBelgium: 152 citing papers, 2% of this breakdown
0%18.3%Other 28.4%

Fields

  • Medicine86.2%
  • Biochemistry, Genetics and Molecular Biology7.1%
  • Pharmacology, Toxicology and Pharmaceutics2.8%
  • Immunology and Microbiology1.6%
  • Nursing0.8%
  • Engineering0.2%
  • Other1.3%

Topics

  • Liver Disease Diagnosis and Treatment15.5%
  • Liver Diseases and Immunity13.3%
  • Liver Disease and Transplantation7.6%
  • Pediatric Hepatobiliary Diseases and Treatments4.6%
  • Drug Transport and Resistance Mechanisms4.4%
  • Gallbladder and Bile Duct Disorders3.1%
  • Other51.5%

Coauthors

All papers

Open in search
  1. The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alison Taylor, Tim Rhodes, Carla Treloar, Claus Petersen, Christoph Schramm, Robert Flisiak, Marieta Y Simonova, Albert Pares, Philip Johnson, Alessandro Cucchetti, Isabel Graupera, Christos Lionis, Elisa Pose, Núria Fabrellas, Ann T Ma, Juan M Mendive, Vincenzo Mazzaferro, Harry Rutter, Helena Cortez-Pinto, Deirdre Kelly, Robyn Burton, Jeffrey V Lazarus, Pere Ginès, Maria Buti, Philip N Newsome, Patrizia Burra, Michael P Manns - The Lancet 2021 cited by 627

  2. EASL Clinical Practice Guidelines on nutrition in chronic liver disease

    Authors: , , , , , , , - Journal of Hepatology 2018 cited by 1,055

  3. Simplified criteria for the diagnosis of autoimmune hepatitis†

    Authors: , , , , , , , , , , , , , , , , , - Hepatology 2008 cited by 1,882

  4. openalex_id:w4200584065

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alison Taylor, Tim Rhodes, Carla Treloar, Claus Petersen, Christoph Schramm, Robert Flisiak, Marieta Simonova, Albert Parés, Philip J. Johnson, Alessandro Cucchetti, Isabel Graupera, Christos Lionis, Elisa Pose, Núria Fabrellas, Ann T., Juan Manuel Mendive, Vincenzo Mazzaferro, Harry Rutter, Helena Cortez‐Pinto, Déirdre Kelly, Robyn Burton, Jeffrey V. Lazarus, Pere Ginès, Marı́a Buti, Philip N. Newsome, Patrizia Burra, Michael P. Manns cited by 245

  5. Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christine N. Manser, George Ν. Dalekos, Bertus Eksteen, Pietro Invernizzi, Christoph P. Berg, Gabi I. Kirchner, Christoph Sarrazin, Vincent Zimmer, Luca Fabris, Felix Braun, Marco Marzioni, Brian D. Juran, Karouk Said, Christian Rupp, Kalle Jokelainen, M Valle, Francesca Saffioti, Angela Cheung, Michael Trauner, Christoph Schramm, Roger W. Chapman, Tom H. Karlsen, Erik Schrumpf, Christian P. Strassburg, Michael P. Manns, Keith D. Lindor, Gideon M. Hirschfield, Bettina E. Hansen, Kirsten Muri Boberg - Gastroenterology 2017 cited by 523

  6. Fibrates for Itch (FITCH) in Fibrosing Cholangiopathies: A Double-Blind, Randomized, Placebo-Controlled Trial

    Authors: , , , , , , , , , , , , , , , - Gastroenterology 2020 cited by 210

  7. Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ulrich Beuers, Rinse K. Weersma, Cisca Wijmenga, Hanns–Ulrich Marschall, Piotr Milkiewicz, Albert Parés, Kimmo Kontula, Olivier Chazouillères, Pietro Invernizzi, Elizabeth C. Goode, Kelly Spiess, Carmel Moore, Jennifer Sambrook, Willem H. Ouwehand, David J. Roberts, John Danesh, Annarosa Floreani, Aliya Gulamhusein, John E. Eaton, Stefan Schreiber, Catalina Coltescu, Christopher L. Bowlus, Velimir A. Luketic, Joseph A. Odin, Kapil Chopra, Kris V. Kowdley, Naga Chalasani, Michael P. Manns, Brijesh Srivastava, George Mells, Richard Sandford, Graeme Alexander, Daniel J. Gaffney, Roger W. Chapman, Gideon M. Hirschfield, Mariza de Andrade, Simon Rushbrook, André Franke, Tom H. Karlsen, Konstantinos N. Lazaridis, Carl A. Anderson - Nature Genetics 2016 cited by 382

  8. A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA

    Authors: , , , , , , , , , , , , , , , , , - Journal of Hepatology 2021 cited by 178

  9. Levels of Alkaline Phosphatase and Bilirubin Are Surrogate End Points of Outcomes of Patients With Primary Biliary Cirrhosis: An International Follow-up Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2014 cited by 489

  10. Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2015 cited by 436

  11. Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid

    Authors: , , , , , , , , , , , , , , , , , - Gastroenterology 2014 cited by 565

  12. Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis

    Authors: , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2019 cited by 277

  13. A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis

    Authors: , , , , , , , , , , , , , , , , , , - Hepatology 2017 cited by 277

  14. Excellent Long-Term Survival in Patients With Primary Biliary Cirrhosis and Biochemical Response to Ursodeoxycholic Acid

    Authors: , , - Gastroenterology 2006 cited by 758

  15. Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rachel Smith, Steve Flack, Victoria Mulcahy, Michael Trauner, Christopher L. Bowlus, Keith D. Lindor, Christophe Corpechot, David Jones, George Mells, Gideon M. Hirschfield, James Wason, Bettina E. Hansen, Richard Sturgess, Christopher G. Healey, Anton Gunasekera, Yiannis Kallis, Gavin Wright, Thiriloganathan Mathialahan, Richard J. Evans, Jaber Gasem, David Ramanaden, Emma Ward, Mahesh Bhalme, Paul Southern, James L. Maggs, Mohamed Yousif, George Mells, Brijesh Srivastava, Matthew Foxton, Carole Collins, Yash Prasad, Francisco Porras-Perez, Tom Yapp, Minesh Patel, Roland Ede, Martyn Carte, Konrad Koss, Prayman Sattianayagam, Charles Grimley, Jude Tidbury, Dina Mansour, Matilda Beckley, Coral Hollywood, John Ramag, Harriet Gordon, Joanne Ridpath, Bob Grover, George Abouda, Ian Rees, Mark Narain, Imroz Salam, Paul Banim, Debasish Das, Helen Matthews, Faiyaz Mohammed, Rebecca Jones, Sambit Sen, G. W. G. Bird, Martin Prince, Geeta Prasad, Paul Kitchen, John Hutchinson, Prakash C. Gupta, David Jones, Amir Shah, Subrata Saha, Katharine Pollock, Stephen Barclay, Natasha McDonald, Simon Rushbrook and 56 more - Gastroenterology 2022 cited by 101

  16. Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Vilas Patwardhan, Cristina Rigamonti, Marco Carbone, Pietro Invernizzi, Laura Cristoferi, Adriaan van der Meer, Rozanne de Veer, Ehud Zigmond, Eyal Yehezkel, Andreas E. Kremer, Ansgar Deibel, Jérôme Dumortier, Tony Bruns, Karsten Große, Georges‐Philippe Pageaux, Aaron Wetten, Jessica Dyson, David G. Jones, Olivier Chazouillères, Bettina Hansen, Victor de Lédinghen - Journal of Hepatology 2022 cited by 116

  17. Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Joost P.H. Drenth, Jessica Dyson, Cumali Efe, Bastian Engel, S. Ferri, R Fontana, Nikolaos Gatselis, Alessio Gerussi, Emina Halilbasic, Neil Halliday, Michael A. Heneghan, Gideon M. Hirschfield, Bart van Hoek, Marianne Hørby Jørgensen, G. Indolfini, Raffaele Iorio, Soo Jeong, D. Jones, Déirdre Kelly, Nanda Kerkar, Florence Lacaille, Craig Lammert, B. Leggett, Marco Lenzi, C Levy, Rodrigo Liberal, Ana Lleò, Ansgar W. Lohse, Susana López, Eléonora De Martin, Valérie A. McLin, Giorgina Mieli‐Vergani, Piotr Milkiewicz, Nitesh Mohan, Luigi Muratori, Gabriella Nebbia, C. van Nieuwkerk, Ye Htun Oo, Alberto Ortega, Albert Parés, Tudor Lucian Pop, Daniel S. Pratt, Tuğrul Pürnak, Giusy Ranucci, Simon Rushbrook, Christoph Schramm, Albert Friedrich Stättermayer, Mark G. Swain, Atsushi Tanaka, Richard Taubert, Débora Raquel Benedita Terrabuio, B. Terziroli, Michael Trauner, Pamela L. Valentino, F. van den Brand, A. Villamil, Staffan Wåhlin, Henriette Ytting, Kalliopi Zachou, Mikio Zeniya - Journal of Hepatology 2022 cited by 173

  18. Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The American Journal of Gastroenterology 2020 cited by 171

  19. Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: The RELIEF trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Hepatology 2012 cited by 561

  20. Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Alimentary Pharmacology & Therapeutics 2019 cited by 116

  21. A placebo-controlled randomised trial of budesonide for PBC following an insufficient response to UDCA

    Authors: , , , , , , , , , , , , , , - Journal of Hepatology 2020 cited by 105

  22. Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain?

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Adèle Delamarre, Natalia Sobenko, Alejandra Villamil, Esli Medina‐Morales, Alan Bonder, Vilas Patwardhan, Cristina Rigamonti, Marco Carbone, Pietro Invernizzi, Laura Cristoferi, Adriaan van der Meer, Rozanne de Veer, Ehud Zigmond, Eyal Yehezkel, Andreas E. Kremer, Ansgar Deibel, Tony Bruns, Karsten Große, Aaron Wetten, Jessica Dyson, David Jones, Jérôme Dumortier, Georges‐Philippe Pageaux, Victor de Lédinghen, Olivier Chazouillères, Fabrice Carrat, the Global & ERN Rare-Liver PBC Study Groups - Hepatology 2023 cited by 78

  23. Combination of fibrates with obeticholic acid is able to normalise biochemical liver tests in patients with difficult‐to‐treat primary biliary cholangitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Alimentary Pharmacology & Therapeutics 2021 cited by 74

  24. Factors Associated With Recurrence of Primary Biliary Cholangitis After Liver Transplantation and Effects on Graft and Patient Survival

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2018 cited by 127